Samuel Zhang

Samuel Zhang

Corporate Officer/Principal at INNOVENT BIOLOGICS, INC.

Health Technology
Consumer Services
Technology Services

Profile

Samuel Zhang is currently the Global Chief Business Officer at Innovent Biologics, Inc. He previously held positions as the Executive Director at Novartis Corp.
from 2013 to 2017, the Chief Business Officer at NeoImmuneTech, Inc. from 2019 to 2022, and the Vice President-Strategy & Business Development at Merus, Inc. from 2017 to 2019.
He also served as the Chief Business Officer at Gracell Biotechnologies, Inc. Dr. Zhang holds a doctorate degree from The Trustees of Columbia University in The City of New York, an undergraduate degree from Peking University, and an MBA from The Wharton School of the University of Pennsylvania.

Samuel Zhang active positions

CompaniesPositionStart
INNOVENT BIOLOGICS, INC. Corporate Officer/Principal 29/04/2024
All active positions of Samuel Zhang

Former positions of Samuel Zhang

CompaniesPositionEnd
NEOIMMUNETECH, INC. Corporate Officer/Principal 31/12/2021
Corporate Officer/Principal 30/04/2019
Director/Board Member 30/06/2017
GRACELL BIOTECHNOLOGIES INC. Corporate Officer/Principal -
See the detail of Samuel Zhang's experience

Training of Samuel Zhang

The Trustees of Columbia University in The City of New York Doctorate Degree
Peking University Undergraduate Degree
The Wharton School of the University of Pennsylvania Masters Business Admin

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Samuel Zhang's experience

Connections

27

1st degree connections

8

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies2
INNOVENT BIOLOGICS, INC.

Health Technology

NEOIMMUNETECH, INC.

Health Technology

Private companies3

Health Technology

Technology Services

Health Technology

See company connections